JNJ compared with PFE: revenue, margins and what each company keeps, and the suppliers and customers both name

JNJJohnson & Johnson

Mkt capRevenueRevenue

PFEPfizer Inc

Mkt capRevenueRevenue

Compare

JNJJohnson & Johnson

PFEPfizer Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

JNJ

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.1%▼−5.73%×1.84

Q2 FY26±2.9%▼−2.69%×0.93

Q1 FY26±3.0%▲+0.90%×0.30

Jan 21 '26±2.8%▼−0.09%×0.04

PFE

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±3.3%▲+1.52%×0.45

Q1 FY26±3.5%▲+0.57%×0.17

= impliedJNJ realized, solidPFE realized, hatchedOne scale, both sides: full bar = 6%× = |realized| ÷ impliedSource: market data

Feb 3 '26

±3.2%

▼−3.34%

×1.03

Q3 FY25±4.2%▼−1.46%×0.36

JNJJohnson & Johnson

273.66▼−0.56%· post 273.74

Mkt cap$657.7BRevenue$25.4BQ3 FY26Revenue$94.2BFY25

PFEPfizer Inc

30.50▲+1.83%· post 30.46

ClosedOct 30 '26

Mkt cap$174.0BRevenue$15.0BQ2 FY26Revenue$62.6BFY25

Compare

ClosedOct 30 '26

JNJJohnson & Johnson

PFEPfizer Inc

273.66▼−0.56%post 273.74

Price

30.50▲+1.83%post 30.46

$657.7B

Mkt cap

$174.0B

Q3 FY26$25.4B

Revenue

$15.0BQ2 FY26

FY25$94.2B

Revenue

$62.6BFY25

JNJ273.66▼−0.56%vsPFE30.50▲+1.83%ClosedOct 30 '26